Fact-checked by Grok 2 weeks ago

Renal plexus

The renal plexus is a complex network of autonomic nerve fibers that provides innervation to the s, comprising primarily sympathetic efferent and afferent components derived from the , intermesenteric plexus, and lumbar originating from spinal segments T9 to L2. These fibers travel along the renal arteries and veins, entering the kidney hilum to regulate key physiological processes such as , sodium reabsorption, renin release via the , and nociceptive signaling. Lacking direct parasympathetic innervation, it is predominantly sympathetic in nature—with postganglionic adrenergic neurons releasing norepinephrine to act on α1- and β1-adrenoceptors—though evidence for indirect parasympathetic contributions remains minimal. The renal plexus arises from preganglionic sympathetic fibers in the intermediolateral column of the thoracic and upper spinal cord (T9–T12, occasionally extending to L2), which in nearby prevertebral ganglia such as the and aorticorenal ganglia before forming postganglionic fibers. Afferent fibers within the plexus convey sensory , including pain from distension or ischemia, projecting to central structures like the , , and to influence systemic responses such as modulation. Efferent sympathetic innervation is densest at the corticomedullary junction, targeting renal arterioles (interlobar, arcuate, and interlobular), glomerular structures, and tubular segments—particularly the and thick ascending limb—to control vascular tone, , and electrolyte handling. Neurotransmitters involved include norepinephrine as the primary mediator, often co-released with and ATP, though the latter's roles in renal function are less defined. Anatomically, the renal plexus is positioned retroperitoneally along the renal vessels, closely associated with the and , and it extends minor branches to the adrenal glands and upper . This innervation integrates with the broader abdominal autonomic system, receiving inputs from the least thoracic splanchnic nerve (T12) and intermesenteric nerves, ensuring coordinated regulation of renal and the renin-angiotensin-aldosterone system in response to systemic demands like volume depletion or . Disruptions in renal plexus activity, such as through procedures, have therapeutic implications for conditions like resistant , underscoring its critical role in cardiovascular .

Anatomy

Location

The renal plexus is a bilateral network of autonomic nerves situated along the , extending from their origin at the to the . It is closely associated with the retroperitoneal positioning of the , accompanying the arteries bilaterally as they course posteriorly to the respective renal veins. This plexus forms a perivascular meshwork surrounding both the renal artery and vein, with its fibers entering the at the hilum alongside the . From there, branches distribute into the , calyces, and parenchyma to reach the renal vasculature and structures. The renal plexus arises in continuity with broader autonomic networks, including the and aorticorenal plexuses.

Formation and components

The renal plexus is formed by 15–20 filaments originating from the and plexus, the aorticorenal ganglia, the lower thoracic (T10–T12), the first lumbar splanchnic nerve, and the aortic plexus. Small ganglia develop along these contributing nerves, contributing to the plexus's networked structure. The plexus's branches supply the directly, targeting its vessels, glomeruli, and tubules, while also extending to the upper via the ureteric plexus. Additional filaments connect to the spermatic or ovarian plexus and reach the fundus of the . Microscopically, the renal comprises a mixture of myelinated and unmyelinated fibers, predominantly the latter (approximately 96% in studied models), with fiber diameters varying from 0.5 to 10 μm—unmyelinated fibers averaging 1.3 μm and myelinated fibers around 3.1 μm, though some myelinated fibers exceed 5 μm.

Innervation

Sympathetic fibers

The sympathetic fibers of the provide efferent innervation to the , originating from preganglionic neurons in the intermediolateral column of the thoracolumbar , specifically segments T9 to L2. These preganglionic fibers exit via the ventral roots and travel through white rami communicantes to primarily in the and aorticorenal ganglia, as well as other prevertebral . Postganglionic fibers then emerge from these ganglia and join the , which forms around the and vein before entering the at the hilum. These postganglionic fibers innervate key renal structures, including the renal arterioles (interlobar, arcuate, interlobular, and glomerular afferent/efferent), juxtaglomerular cells, and segments of the such as the , thick ascending limb, distal tubule, and collecting duct. The innervation supports vascular and , with fibers distributing along the vascular tree and into the renal . The sympathetic fibers are predominantly noradrenergic, releasing norepinephrine that acts on adrenergic receptors to elicit physiological responses. of alpha-1 adrenoceptors on vascular induces , reducing renal blood flow, while beta-1 adrenoceptors on juxtaglomerular cells stimulate renin , contributing to the of the renin-angiotensin-aldosterone . The density of these fibers is highest in the , particularly around , with a notable concentration at the corticomedullary border and decreasing toward the inner medulla.

Parasympathetic and sensory fibers

The renal plexus receives sparse parasympathetic innervation, primarily consisting of cholinergic fibers that originate from the vagus nerve (cranial nerve X) via the celiac plexus. These postganglionic fibers are identified through immunostaining for choline acetyltransferase and vesicular acetylcholine transporter, with cholinergic ganglion cells present within the renal nerve plexus in a subset of cases. Evidence for this innervation remains limited, as most studies emphasize sympathetic dominance, but retrograde tracing confirms a vagal brain-kidney axis involving projections from the dorsal motor nucleus of the vagus to the renal vasculature and pelvis. Functionally, these fibers may promote vasodilation in renal arteries and segmental branches through activation of muscarinic acetylcholine receptors, particularly mAChR3 expressed on endothelial cells, though direct physiological confirmation is ongoing. In contrast, sensory afferent fibers constitute a significant component of the renal plexus, comprising unmyelinated C-fibers and a smaller population of myelinated A-delta fibers that convey signals from the to the . These afferents are densest in the and papillae, with extensions to the cortex including glomeruli and tubules, enabling detection of mechanical and chemical stimuli. Projections ascend via dorsal root ganglia at spinal levels T10 to L1, entering the through the dorsal horn (laminae I and III-V), and continue centrally to nuclei such as the nucleus tractus solitarius and rostral ventrolateral medulla, as well as the hypothalamic paraventricular nucleus. Afferent C-fibers primarily transmit nociceptive signals, eliciting such as from obstruction, ischemia, or inflammation in the , while A-delta fibers contribute to sharper, localized sensations. Non-nociceptive roles include relaying information on and blood volume via mechanoreceptors and chemoreceptors, influencing systemic through reflexes that modulate sympathetic outflow. Pain referral occurs to dermatomes T10-L1 in the anterior and flanks, mediated by pathways involving the least from the 12th thoracic paravertebral to the renal plexus.

Functions

Vascular regulation

The renal plexus provides sympathetic innervation to the renal vasculature, primarily through efferent fibers originating from the and intermesenteric plexuses, which release norepinephrine to induce . Sympathetic activation targets both afferent and , causing constriction that reduces renal blood flow (RBF) and (GFR), thereby conserving during stress responses. Under basal conditions, ongoing sympathetic tone from the renal plexus maintains RBF at approximately 20-25% of , ensuring adequate for while preventing excessive loss. Acute elevations in sympathetic activity, triggered by unloading or stimulation during or , further constrict renal vessels to redirect blood to vital organs, with the magnitude of response graded by the intensity of neural discharge. This neural control interacts with intrinsic renal autoregulation mechanisms, such as myogenic responses in vascular and via the , where the plexus modulates tone without fully overriding these local safeguards that stabilize RBF across a wide range of pressures. Sympathetic fibers exhibit dense around arcuate and interlobular arteries, as well as glomerular arterioles, enabling precise regulation of cortical and medullary distribution.

Renin-angiotensin system modulation

The renal plexus provides sympathetic innervation to the juxtaglomerular cells of the , primarily through beta-1 adrenergic receptors, which stimulates renin secretion in response to reduced or . Renin secreted by these cells cleaves circulating angiotensinogen to form I, which is then converted to II by mainly in the pulmonary ; II promotes systemic and stimulates aldosterone release from the , resulting in renal sodium and water retention to restore and . Chronic sympathetic overactivity mediated by the renal plexus enhances renin-angiotensin-aldosterone system (RAAS) activation, which sustains elevated and contributes to renal through mechanisms such as glomerular hyperfiltration and . Renal sympathetic activity from the plexus correlates positively with levels, where increased firing thresholds directly elevate renin release and subsequent RAAS components.

Sensory transmission

The renal plexus contains afferent sensory fibers that transmit visceral sensations from the , primarily originating from the and . These unmyelinated C-fibers and thinly myelinated Aδ-fibers detect mechanical distension, ischemia, and , relaying signals to the via the for processing of pain and other sensations. In conditions such as caused by ureteral obstruction, activation of these afferents leads to in the flank, lower , or , often radiating in a dermatomal due to with inputs at spinal levels T10-L1. Beyond , low-threshold non-painful afferents in the renal plexus monitor renal interstitial osmolarity and volume changes, projecting to the to influence mechanisms and antidiuretic hormone (ADH) release for fluid . These C-fibers exhibit polymodal responsiveness, activating in response to noxious thermal stimuli or chemical irritants such as protons and capsaicin-like compounds.

Clinical significance

Role in

The renal plexus, primarily composed of sympathetic fibers, contributes to hypertension pathophysiology through elevated efferent sympathetic outflow that promotes renal sodium retention and impairs pressure . This outflow stimulates alpha-1 adrenergic receptors on renal tubules, increasing sodium and reducing urinary sodium excretion (), which in turn expands volume and sustains elevated arterial pressure. In , renal sympathetic nerve activity (RSNA) is elevated, contributing to overactivation of the renin-angiotensin-aldosterone system (RAAS) via increased renin release from juxtaglomerular cells and to through and reduced bioavailability. This heightened RSNA correlates with disease severity and perpetuates a vicious cycle of and vascular remodeling. Animal models of demonstrate the causal role of renal sympathetic activity, where renal reduces systolic blood pressure by approximately 10-20 mmHg in spontaneously hypertensive rats and other models by interrupting this pathway. evidence from microneurography studies, which measure muscle sympathetic activity (MSNA) as a for systemic sympathetic drive including RSNA, shows a strong positive between elevated sympathetic burst rates and levels in patients with .

Renal denervation procedures

Renal denervation procedures aim to disrupt the sympathetic innervation of the kidneys provided by the renal plexus to treat conditions such as resistant . The primary approach is catheter-based renal (RDN), a minimally invasive endovascular technique performed via access. In this method, a is advanced to the renal arteries, where energy is delivered to ablate the perivascular nerves. Two main technologies are used: , which employs electrodes to generate heat and target nerves up to 7 mm from the arterial while sparing the , and ablation, which uses a balloon-mounted to emit focused energy waves, cooling the artery to protect it during nerve disruption in the . These procedures substantially reduce renal sympathetic activity (RSNA), with preclinical animal models demonstrating 80-90% of efferent sympathetic fibers, leading to decreased norepinephrine spillover and lowering. Catheter-based RDN is indicated primarily for patients with resistant hypertension, defined as uncontrolled blood pressure despite adherence to at least three antihypertensive medications of different classes, including a diuretic. The procedure received CE Mark approval in Europe in 2010 for the Symplicity system, based on early open-label trials showing significant blood pressure reductions. In November 2023, the US Food and Drug Administration (FDA) approved two renal denervation systems—the Symplicity Spyral (Medtronic) and Paradise (Recor Medical)—for the treatment of hypertension in adults with uncontrolled blood pressure despite lifestyle and pharmacological interventions. Sham-controlled randomized trials, such as SPYRAL HTN-OFF MED and RADIANCE-HTN TRIO, have confirmed modest but consistent ambulatory systolic blood pressure reductions of 5-10 mm Hg at 3-6 months post-procedure compared to sham controls, with effects sustained up to 3 years or longer in follow-up data. As of 2025, renal denervation is included in the American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines as an option for select patients with resistant hypertension. Historically, surgical renal involved open procedures such as thoracolumbar sympathectomy, which interrupted renal sympathetic outflow during operations for severe in the mid-20th century; these were effective in reducing by 20-30 mm Hg but carried high risks of morbidity, including and , leading to their with the advent of antihypertensive . Today, surgical approaches are rare and reserved for exceptional cases, supplanted by the safer, methods. Clinical outcomes of RDN show effectiveness in approximately 60-70% of patients, with sustained ambulatory systolic blood pressure reductions of 5-9 mm observed up to 3 years in pivotal trials, though individual responses vary based on baseline sympathetic activity and procedural completeness. Risks are low overall, with major adverse events occurring in less than 1% of cases; potential complications include (0.2-2% incidence, typically within the first year and rarely requiring intervention) and partial reinnervation, which may occur over time but has not been shown to fully reverse blood pressure benefits in long-term follow-up. In renal transplantation, the procedure inherently results in complete of the allograft due to surgical severance of the renal plexus, yet transplanted kidneys maintain normal function through intrinsic autoregulatory mechanisms, such as , without reliance on extrinsic neural input.

References

  1. [1]
    Anatomy, Abdomen and Pelvis: Kidney Nerves - StatPearls - NCBI
    Innervation of the kidney includes both afferent and efferent fibers of the renal plexus. This plexus is a combination of fibers originating from the celiac ...
  2. [2]
    Neuroanatomy - Neural Control of Renal Function - NCBI Bookshelf
    The efferent renal nerves are postganglionic, and the majority of these are adrenergic, ie, they contain norepinephrine varicosities at their nerve terminals.
  3. [3]
    Anatomy Tables - Kidneys & Retroperitoneum
    brs. to the renal plexus, vascular smooth muscle of the brs. of the renal aa. pain from the kidney, suprarenal gland, upper ureter, a sympathetic ganglion ...
  4. [4]
    Anatomy, Abdomen and Pelvis, Renal Artery - StatPearls - NCBI - NIH
    Aug 8, 2023 · Nerves. The kidneys are surrounded by the renal plexus, whose fibers course along with the renal artery on each side. There is also input ...
  5. [5]
    Kidney: Gross Anatomy, Renal Fascia, Vessels, and Nerves
    The renal plexus is located around the renal artery and contains postganglionic fibers from the sympathetic nervous system (Th10 to L2). The nerve fibers from ...
  6. [6]
    Renal plexus - e-Anatomy - IMAIOS
    The renal plexus is formed by filaments from the celiac ganglia and plexus, aorticorenal ganglia, lower thoracic splanchnic nerves and first lumbar ...Missing: components | Show results with:components
  7. [7]
    Qualitative and quantitative morphology of renal nerves in C57BL/6J ...
    Nov 2, 2002 · Most of the myelinated fibers in the renal nerves were small (total fiber diameter average = 3.1 ± 0.9 μm (Table 1)). Myelinated fibers had ...
  8. [8]
    Ultrastructural anatomy of the renal nerves in rats - PubMed
    The diameters of myelinated fibers showed an unimodal distribution with a peak at 3.0 microm but more than 17% of the fibers showed diameters larger than 5 ...Missing: range | Show results with:range
  9. [9]
    Anatomical Evidence for Parasympathetic Innervation of the Renal ...
    There Are Cholinergic Ganglion Cells within the Renal Nerve Plexus. Generally, parasympathetic postganglionic neurons are either located in discrete ganglia ...
  10. [10]
    Cardiorenal Syndrome: The Role of Neural Connections between ...
    Renal afferent nerves consist of mainly slow conducting unmyelinated (primarily C-fibers) with a small population of faster conducting myelinated (A-delta ...
  11. [11]
    Comprehensive mapping of sensory and sympathetic innervation of ...
    Oct 22, 2024 · Using light-sheet and confocal microscopy, we generated anatomical maps of kidney innervation across development.
  12. [12]
    Spinal projections of renal afferent nerves in the rat - PubMed
    All neurons were located at spinal levels T10 to L1. Most neurons responded to both noxious and non-noxious mechanical cutaneous stimuli from relatively large ...Missing: hypothalamus insula
  13. [13]
    Pain management in polycystic kidney disease
    From the 12th thoracic paravertebral ganglion, nerves travel via the least splanchnic nerve to synapse either in the aorticorenal ganglion or in the renal ...
  14. [14]
    Renal sympathetic nervous system and the effects of denervation on ...
    This decrease in flow is primarily mediated through increased afferent renal arteriolar vasoconstriction. There is also efferent arteriolar constriction, which ...Renal Sympathetic... · Renal Denervation · Role Of Sympathetic Nervous...
  15. [15]
    Role of the Sympathetic Nervous System and Its Modulation in ...
    Mar 29, 2018 · Renal sympathetic nerves play a key role in blood pressure regulation and play a crucial role in the pathogenesis of hypertension, a condition ...
  16. [16]
    Kidney Innervation - an overview | ScienceDirect Topics
    Activation of β 1 adrenergic receptors on JG cells ultimately increases renin secretion , thereby increasing levels of circulating angiotensin II and ...
  17. [17]
    The renal renin-angiotensin system
    The juxtaglomerular cells are innervated by sympathetic nerve fibers. Activation of renal sympathetic nerves and stimulation of β-adrenergic receptors increases ...Missing: plexus | Show results with:plexus
  18. [18]
    Physiology, Renin Angiotensin System - StatPearls - NCBI Bookshelf
    Renin cleaves the angiotensinogen's N-terminal and leads to angiotensin I's formation. This enzyme is expressed on plasma membranes of vascular endothelial ...
  19. [19]
    Overview of the renin-angiotensin system - UpToDate
    Oct 2, 2025 · Angiotensin II mediates vasoconstriction as well as aldosterone release from the adrenal gland, resulting in sodium retention and increased ...
  20. [20]
    The role of sympathetic nervous activity in renal injury and end ...
    Mar 26, 2010 · Renal sympathetic nerve hyperactivity may contribute to renal injury in hypertension and obesity. Elevated renal sympathetic nerve activity is ...
  21. [21]
    Sympathetic Overactivity in Chronic Kidney Disease - PMC - NIH
    Aug 2, 2017 · This elevation in sympathetic nerve activity (SNA) not only contributes to hypertension but also plays a detrimental role in the progression of CKD.
  22. [22]
    Sympathetic hyperactivity in chronic kidney disease: Pathogenesis ...
    There is now evidence that CKD is often characterized by an activated sympathetic nervous system. This may contribute to the pathogenesis of renal hypertension, ...<|separator|>
  23. [23]
    Kidney Innervation - an overview | ScienceDirect Topics
    Elevations in renal sympathetic nerve activity (RSNA) increase renin release, tubular sodium reabsorption, and renal vascular resistance (RVR) thereby ...
  24. [24]
    Role of the Sympathetic Nervous System in Regulating Renin ... - NIH
    This increase in sympathetic activity is then responsible for an increase in renal afferent arteriolar constriction, leading to an increase in renin secretion ...
  25. [25]
    Responses of primate spinothalamic tract neurons to renal pelvic ...
    1. Experiments were performed to examine responses of spinothalamic tract (STT) neurons to distension of the renal pelvis.
  26. [26]
    Diagnosis and Initial Management of Kidney Stones - AAFP
    Apr 1, 2001 · The pain of renal colic often begins as vague flank pain. Patients frequently dismiss this pain until it evolves into waves of severe pain. It ...
  27. [27]
    Electrophysiological Characteristics of Primate ... - PubMed - NIH
    Spinothalamic tract (STT) neurons in the T10-L3 segments were studied for responses to renal and somatic stimuli. A total of 90 neurons was studied in 25 ...
  28. [28]
    Role of the afferent renal nerves in sodium homeostasis and blood ...
    May 10, 2019 · The mechanosensitive afferent renal nerves contribute to an acute natriuretic sympathoinhibitory reno-renal reflex that may be integrated within ...
  29. [29]
    Renal afferents and hypertension - PubMed
    Afferent renal nerves have been shown to carry information from renal chemoreceptors, which respond to changes in the composition of the interstitial fluid ...
  30. [30]
    The Sympathetic Nervous System and Hypertension
    Increased renal sympathetic nerve activity (RSNA) is known to be a factor capable of decreasing renal excretory function. The renal effects of increased RSNA ...
  31. [31]
    A clinician's perspective of the role of renal sympathetic nerves in ...
    Stimulation of the renal sympathetic nerves increases norepinephrine production that results in increased sodium reabsorption by the renal tubular ...
  32. [32]
    Sympathetic neural control of the kidney in hypertension - PubMed
    Efferent renal sympathetic nerve activity is elevated in human essential hypertension as well as in several forms of experimental hypertension in animals.
  33. [33]
    Renal denervation therapy beyond resistant hypertension - PMC
    Efferent sympathetic activity has three major effects on the kidney: (I) increased renin secretion; (II) increased sodium reabsorption in the tubules; and (III) ...The Sympathetic Nervous... · Rdn Trials: Lessons Learned... · Table 1. Summary Data Of...
  34. [34]
    Oxidative Stress and Sympathetic Activity in Hypertension
    These investigators have demonstrated that RSNA is increased in the two-kidney, one-clip (2K-1C) model of hypertension, confirming a role for increased SNS ...
  35. [35]
    Renal Deafferentation Prevents Progression of Hypertension and ...
    Sep 20, 2021 · Renal denervation is effective in alleviating hypertension associated with elevation of renal sympathetic nerve activity (RSNA) in chronic kidney disease (CKD).
  36. [36]
    Full article: Safety and efficacy of extravascular renal denervation ...
    This study investigated the safety and efficacy of the HyperQure™ extravascular renal denervation (RDN) system in a swine model of mild hypertension.Surgical Procedures · Extravascular Renal... · Renal Denervation And Sham...
  37. [37]
    Effects of Renal Denervation on Sympathetic Nerve Traffic and ...
    Jan 11, 2023 · We examined this issue by performing a meta-analysis of the microneurographic studies evaluating the BP and muscle sympathetic nerve activity ( ...
  38. [38]
  39. [39]
    Renal Denervation for the Treatment of Hypertension
    Aug 5, 2024 · Although further research is clearly needed, renal denervation presents a novel treatment strategy for patients with uncontrolled blood pressure.
  40. [40]
    Renal Denervation as a Therapeutic Approach for Hypertension
    Oct 12, 2009 · Surgical renal denervation has been shown to be an effective means of reducing sympathetic outflow to the kidneys, increasing urine output ( ...Missing: drop | Show results with:drop
  41. [41]
    Is renal denervation a cure for drug-resistant disease? - Nature
    Dec 17, 2010 · The Symplicity® system has been approved for treatment of patients with drug-resistant hypertension in Europe and Australia, and will be tested ...
  42. [42]
    Renal Sympathetic Denervation – A Review of Applications in ...
    Effect of decreased renal sympathetic nerve activity on renal tubular sodium reabsorption. ... Renal sympathetic denervation reduces left ventricular ...Missing: source | Show results with:source
  43. [43]
    Renal Denervation for Hypertension: A Systematic Review and Meta ...
    The randomized placebo-controlled trials show consistently that renal denervation provides significant reduction in ambulatory and office blood pressure.
  44. [44]
    lessons from renal transplantation reconsidered - PubMed - NIH
    Renal transplantation assures complete denervation of the kidney. Human renal transplantation provided an opportunity to examine the consequences of renal ...